Sunesis Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
The drawbacks associated with protein drugs--including the injectable mode of delivery and the high costs of goods--have led a number of biotech and pharmaceutical companies to use their protein engineering capabilities for small molecule drug discovery. Fledging Sunesis Pharmaceuticals Inc. has leapt into the fray with what its management believes is a unique combination of robust proprietary technology and integrated capabilities in medicinal chemistry and protein engineering.